Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study

NCT05591703 is registered in ClinicalTrials.gov with Spark Biomedical, Inc. as lead sponsor.

NCT NCT05591703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05591703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
Lead sponsor
Spark Biomedical, Inc.
Phase
Observational
Overall status
Completed
Start date
November 21, 2022
Completion date
January 31, 2025
Enrollment
32 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder, relapse